当前位置: 首页 > 期刊 > 《特别健康.下半月》 > 2014年第3期 > 正文
编号:12973349
间充质干细胞治疗急性肾损伤的临床应用可行性探讨(3)
http://www.100md.com 2014年3月1日 《特别健康·下半月》2014年第3期
     [8] Ilancheran S, Michalska A, Peh G, et al.Stem cells derived from human fetal membranes display multilineage differentiation potential [J].Biol Rep rod, 2007, 77(3): 577-588

    [9] 张路, 方宁, 陈代雄, 等.人羊膜间充质细胞具有向心肌样细胞分化的特性[J].中国生物工程杂志, 2007, 27 (12): 84289

    [10] Herrera M B,Bussolati B,Bruno S,et a1.Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury[H].Int J Mol Med,2004,14(6):1035-1041

    [11] Morigi M,Imberti B,Zoia C,et a1.Mesenehymal stem cells are renotropie,.helping to repair the kidney and improve function in acute renal failure[J].J Am Soc Nephrol,2004,15(7):1794-1804

    [12] Imberti B, Morigi M, Tomasoni S, Rota C,Corna D, Longaretti L, Rottoli D, ValsecchiF, Benigni A, Wang J, Abbate M, Zoja C,Remuzzi G: Insulin-like growth factor-1sustains stem cell mediated renal repair.JAm Soc Nephrol 2007; 18: 2921-2928

    [13] Togel F, Weiss K, Yang Y, Hu Z, Zhang P,Westenfelder C: Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury.Am J Physiol Renal Physiol 2007; 292:F1626-F1635

    [14] Togel F,Cohen A,Zhang P,et a1.Autologous and logeneic marrow stromal cells are safe and efective for the treatment of acute kidney injury[J].Stem Cells Dev,2009,1 8(3):475-485 (甘露)
上一页1 2 3